RU2008102238A - Таблетка, содержащая труднорастворимый активный ингредиент - Google Patents

Таблетка, содержащая труднорастворимый активный ингредиент Download PDF

Info

Publication number
RU2008102238A
RU2008102238A RU2008102238/15A RU2008102238A RU2008102238A RU 2008102238 A RU2008102238 A RU 2008102238A RU 2008102238/15 A RU2008102238/15 A RU 2008102238/15A RU 2008102238 A RU2008102238 A RU 2008102238A RU 2008102238 A RU2008102238 A RU 2008102238A
Authority
RU
Russia
Prior art keywords
tablet containing
active ingredient
soluble active
containing differently
differently soluble
Prior art date
Application number
RU2008102238/15A
Other languages
English (en)
Other versions
RU2420278C2 (ru
Inventor
Сигеюки МАРУНАКА (JP)
Сигеюки Марунака
Макото ФУКУТА (JP)
Макото Фукута
Original Assignee
Такеда Фармасьютикал Компани Лимитед (Jp)
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37570471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2008102238(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютикал Компани Лимитед (Jp), Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед (Jp)
Publication of RU2008102238A publication Critical patent/RU2008102238A/ru
Application granted granted Critical
Publication of RU2420278C2 publication Critical patent/RU2420278C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Таблетка, содержащая, приблизительно от 3 до приблизительно 50 вес.% (вес./вес.) (S)-N-[2-(1,6,7,8-тетрагидро-2H-индено[5,4-b]фуран-8-ил)этил]пропионамида в расчете на целую таблетку, стеарат магния и гидроксипропилцеллюлозу, имеющую вязкость от приблизительно 1 до приблизительно 4 мПа·с.

Claims (1)

  1. Таблетка, содержащая, приблизительно от 3 до приблизительно 50 вес.% (вес./вес.) (S)-N-[2-(1,6,7,8-тетрагидро-2H-индено[5,4-b]фуран-8-ил)этил]пропионамида в расчете на целую таблетку, стеарат магния и гидроксипропилцеллюлозу, имеющую вязкость от приблизительно 1 до приблизительно 4 мПа·с.
RU2008102238/15A 2005-06-22 2006-06-21 Таблетка, содержащая труднорастворимый активный ингредиент RU2420278C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-182415 2005-06-22
JP2005182415 2005-06-22

Publications (2)

Publication Number Publication Date
RU2008102238A true RU2008102238A (ru) 2009-07-27
RU2420278C2 RU2420278C2 (ru) 2011-06-10

Family

ID=37570471

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008102238/15A RU2420278C2 (ru) 2005-06-22 2006-06-21 Таблетка, содержащая труднорастворимый активный ингредиент

Country Status (18)

Country Link
US (1) US8821926B2 (ru)
EP (1) EP1900368B1 (ru)
JP (1) JP5220408B2 (ru)
KR (1) KR20080027783A (ru)
CN (1) CN101247805B (ru)
AU (1) AU2006260201B2 (ru)
BR (1) BRPI0611618A2 (ru)
CA (1) CA2612090C (ru)
CR (1) CR9632A (ru)
ES (1) ES2366381T3 (ru)
HK (1) HK1115315A1 (ru)
IL (1) IL187916A (ru)
MX (1) MX2007015783A (ru)
NO (1) NO20080248L (ru)
NZ (1) NZ564407A (ru)
RU (1) RU2420278C2 (ru)
WO (2) WO2006137443A1 (ru)
ZA (1) ZA200711048B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20125420B (en) * 2006-08-10 2012-03-26 Takeda Pharmaceutical Solid pharmaceutical composition comprising benzimidazole compound
WO2009084023A2 (en) * 2007-10-19 2009-07-09 Glenmark Generics Limited Amorphous ramelteon and process for the preparation thereof
ES2513415T3 (es) * 2009-01-21 2014-10-27 F. Hoffmann-La Roche Ag Composiciones farmacéuticas que comprenden un profármaco inhibidor de la polimerasa del VHC
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
CN104546746A (zh) * 2013-10-28 2015-04-29 南京长澳医药科技有限公司 一种雷美替胺片剂及其制备工艺
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
JP7407364B2 (ja) * 2019-02-12 2024-01-04 日本ジェネリック株式会社 ラメルテオン含有固形製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
NZ330656A (en) * 1996-03-08 1999-06-29 Takeda Chemical Industries Ltd Tricyclic compounds, their production and use
JPH11322584A (ja) * 1998-05-07 1999-11-24 Sawai Pharmaceutical Co Ltd ベザフィブラート徐放性製剤
WO1999063977A2 (en) * 1998-06-09 1999-12-16 Takeda Chemical Industries, Ltd. Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
CN1227001C (zh) * 1999-09-10 2005-11-16 兰贝克赛实验室有限公司 依托度酸的缓释制剂
WO2002040054A1 (fr) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Preparation pharmaceutique contenant de la copolyvidone
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP4754211B2 (ja) 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法

Also Published As

Publication number Publication date
JP5220408B2 (ja) 2013-06-26
US20090036522A1 (en) 2009-02-05
JPWO2006137443A1 (ja) 2009-01-22
CN101247805B (zh) 2012-10-10
BRPI0611618A2 (pt) 2011-05-31
AU2006260201A1 (en) 2006-12-28
US8821926B2 (en) 2014-09-02
CN101247805A (zh) 2008-08-20
ZA200711048B (en) 2009-05-27
HK1115315A1 (en) 2008-11-28
CR9632A (es) 2008-02-04
RU2420278C2 (ru) 2011-06-10
NZ564407A (en) 2011-03-31
EP1900368A4 (en) 2009-08-12
CA2612090C (en) 2014-06-10
CA2612090A1 (en) 2006-12-28
IL187916A0 (en) 2008-03-20
KR20080027783A (ko) 2008-03-28
IL187916A (en) 2013-11-28
NO20080248L (no) 2008-01-14
EP1900368A1 (en) 2008-03-19
ES2366381T3 (es) 2011-10-19
MX2007015783A (es) 2008-02-21
EP1900368B1 (en) 2011-05-11
AU2006260201B2 (en) 2011-10-20
WO2006137443A1 (ja) 2006-12-28
WO2007004425A1 (ja) 2007-01-11

Similar Documents

Publication Publication Date Title
RU2008102238A (ru) Таблетка, содержащая труднорастворимый активный ингредиент
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
NO20080177L (no) 1-[(3-Hydroksyadamant-1-ylamino)acetyl]pyrrolidin-2(S)-karbonitrilformulering med modifisert frigivning
MA51204B1 (fr) Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EA200970067A1 (ru) Агонисты ep2
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor
RU2008135718A (ru) Композиции клопидогреля бисульфата
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
MA38679A1 (fr) Modulateurs du récepteur de cxcr7
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
EA201071309A1 (ru) Твердая фармацевтическая композиция
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
RU2008147216A (ru) Жидкая лекарственная композиция
HK1075390A1 (en) Citalopram for the treatment of elevated blood pressure
EA200800758A1 (ru) Ингибиторы фермента интегразы вич
EA200701741A1 (ru) Композиция, содержащая окаперидон
EA200901205A1 (ru) Фармацевтическая композиция, содержащая соль розиглитазона
UA132547U (uk) Лікарський засіб знеболювальної та спазмолітичної дії
WO2005042476A3 (en) Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors
TH80747B (th) ยาเม็ดให้การแตกตัวที่ประกอบด้วยไลคาร์บาซิพีน

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20140622